Pharma Journalist -

SMi Reports: An Interview with Martin Everett, Chief Scientific Officer, at Antabio, who will be speaking at SMi’s highly anticipated 22nd Annual Superbugs & Superdrugs Conference…
Read More...

NAGASE & CO., LTD. and Osaka University have launched DDS Products Joint Development Research Chair, a course dedicated to research in the development of production methods of…
Read More...

SMi reports: Exclusive Chair letter invite released for Pre-Filled Syringes West Coast 2021 SMi Group’s 5th annual Pre-Filled Syringes West Coast conference is set to return on the…
Read More...

Revolutionary change in manufacturing strategies and device designs for new modalities are currently driving the inhalation industry forward. To achieve greater acceleration within this…
Read More...

BioCryst Pharmaceuticals, Inc. announced the first patients have been dosed with BCX9930 in a proof of concept trial in paroxysmal nocturnal hemoglobinuria (PNH). These patients were…
Read More...

Urovant Sciences announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for once-daily 75 mg vibegron for the…
Read More...

AMAG Pharmaceuticals, Inc. announced changes to its medical development organization. Effective March 31, 2020, Julie Krop, M.D., Executive Vice President and Chief Medical Officer,…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the Elecsys GALAD score. This algorithmic score combines gender and age…
Read More...

Takeda Pharmaceutical Company Limited will share with members of the United States Congress that it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin…
Read More...

Vir Biotechnology, Inc.and Alnylam Pharmaceuticals, Inc. announced an expansion of their existing collaboration to include the development and commercialization of RNAi therapeutics…
Read More...